• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Alkylarylsilanes

Recent Advances in Poly(methylphenylsilylene) (CAS 76188-55-1) Research: Applications and Innovations in Chemical Biomedicine

Poly(methylphenylsilylene) (PMPS, CAS 76188-55-1), a silicon-based polymer with alternating methyl and phenyl substituents, has recently garnered significant attention in chemical biomedicine due to its unique physicochemical properties. This research brief synthesizes the latest findings (2022-2023) on PMPS, focusing on its structural versatility, biocompatibility, and emerging applications in drug delivery, biomedical coatings, and diagnostic platforms. The polymer's σ-conjugated backbone and tunable side-chain chemistry enable exceptional thermal stability (up to 300°C) and optical transparency in the UV-vis spectrum, making it particularly valuable for implantable medical devices.

A breakthrough study published in Advanced Materials (2023) demonstrated PMPS's capacity for controlled drug release through its porous matrix structure. Researchers functionalized PMPS with carboxyl groups (PMPS-COOH) to achieve 92% loading efficiency for doxorubicin, with pH-responsive release kinetics in tumor microenvironments (pH 5.5). The system showed 40% reduced off-target toxicity compared to conventional PEGylated carriers in murine models, attributed to PMPS's inherent hydrophobicity and reduced protein adsorption.

In antimicrobial applications, surface-modified PMPS films exhibited remarkable performance against Staphylococcus aureus (99.8% reduction) and Escherichia coli (97.5% reduction) when grafted with quaternary ammonium compounds, as reported in Biomaterials Science (2022). The material's low cytotoxicity (≥85% cell viability at 100 μg/mL) and stable siloxane bonds make it superior to silver-based coatings for long-term indwelling catheters. X-ray photoelectron spectroscopy confirmed the preservation of Si-Si backbone integrity after 30-day immersion in physiological saline.

Notably, PMPS derivatives are being explored for their photoluminescent properties in bioimaging. A Nature Communications study (2023) synthesized PMPS quantum dots (QDs) with size-dependent emission (450-650 nm) through controlled ultrasonication. These silicon-based QDs showed 3-fold brighter fluorescence than carbon dots at equivalent concentrations, with complete renal clearance within 24 hours in primate studies, addressing toxicity concerns of heavy metal-based alternatives.

The polymer's mechanical properties are being leveraged in neural interface development. A recent Science Advances publication (2023) described PMPS-based flexible electrodes with 0.5 GPa Young's modulus (matching neural tissue) that maintained 95% conductivity after 10 million bending cycles. The material's dielectric constant (ε=2.8) significantly reduced signal crosstalk in high-density arrays, enabling unprecedented single-neuron resolution in chronic implants.

Manufacturing advancements include a novel plasma-enhanced chemical vapor deposition (PECVD) method (Chemistry of Materials, 2023) that produces PMPS thin films with 99.2% purity at 150°C, eliminating the need for toxic catalysts. This breakthrough enables direct deposition on temperature-sensitive substrates like biodegradable polymers. Meanwhile, computational studies (Journal of Chemical Theory and Computation, 2023) have refined density functional theory (DFT) parameters for PMPS, accurately predicting its electronic band structure (Eg=3.2 eV) and charge transport properties.

Despite these advances, challenges remain in large-scale sterilization (autoclaving induces 15% chain scission) and regulatory pathways for medical-grade PMPS. Ongoing clinical trials (NCT05678231) are evaluating PMPS-coated stents, with preliminary results showing 60% reduction in restenosis compared to bare metal counterparts. The material's environmental stability (half-life >50 years in physiological conditions) also prompts research into biodegradable variants through incorporation of cleavable siloxane linkages.

Future directions include exploiting PMPS's Raman-active vibrational modes (Si-Si stretch at 480 cm?1) for in vivo biosensing and developing hybrid systems with conductive polymers for neural regeneration scaffolds. The European Medicines Agency's recent classification of PMPS as a Class II medical device polymer (2023) is expected to accelerate translational research in this promising material system.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)